Abstract
This is a report of a case of steroid resistant severe Type 2 reaction that was managed with methotrexate and prednisolone. Synergistic action of both the drugs in severe Type 2 reaction make them one of the preferred combinations in the absence of other agents such as thalidomide.
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use
-
Anti-Inflammatory Agents / therapeutic use
-
Drug Synergism
-
Erythema Nodosum / drug therapy*
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Leprosy, Lepromatous / drug therapy*
-
Male
-
Methotrexate / therapeutic use*
-
Middle Aged
-
Prednisolone / therapeutic use
-
Treatment Failure
-
Treatment Outcome
Substances
-
Adrenal Cortex Hormones
-
Anti-Inflammatory Agents
-
Immunosuppressive Agents
-
Prednisolone
-
Methotrexate